Concepts (183)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Radiotherapy Planning, Computer-Assisted | 26 | 2013 | 1679 | 2.080 |
Why?
|
| Movement | 23 | 2011 | 1490 | 1.760 |
Why?
|
| Respiration | 21 | 2011 | 1668 | 1.710 |
Why?
|
| Radiotherapy, Conformal | 10 | 2009 | 549 | 1.250 |
Why?
|
| Four-Dimensional Computed Tomography | 5 | 2013 | 141 | 1.250 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 8 | 2013 | 1232 | 0.910 |
Why?
|
| Lung Neoplasms | 20 | 2011 | 13593 | 0.660 |
Why?
|
| Phantoms, Imaging | 12 | 2011 | 2533 | 0.630 |
Why?
|
| Imaging, Three-Dimensional | 11 | 2010 | 4077 | 0.570 |
Why?
|
| Tomography, X-Ray Computed | 19 | 2010 | 20776 | 0.520 |
Why?
|
| Thoracic Neoplasms | 2 | 2013 | 269 | 0.420 |
Why?
|
| Radiotherapy, High-Energy | 1 | 2013 | 228 | 0.420 |
Why?
|
| X-Ray Film | 1 | 2012 | 31 | 0.410 |
Why?
|
| X-Ray Intensifying Screens | 1 | 2012 | 32 | 0.410 |
Why?
|
| Artifacts | 6 | 2010 | 1942 | 0.370 |
Why?
|
| Protons | 3 | 2011 | 1113 | 0.350 |
Why?
|
| Linoleic Acids | 1 | 2010 | 39 | 0.350 |
Why?
|
| Radiotherapy, Computer-Assisted | 3 | 2011 | 90 | 0.340 |
Why?
|
| Radiotherapy | 5 | 2010 | 1506 | 0.340 |
Why?
|
| Arachidonate 15-Lipoxygenase | 1 | 2010 | 84 | 0.330 |
Why?
|
| Organs at Risk | 1 | 2011 | 368 | 0.330 |
Why?
|
| Fluoroscopy | 3 | 2011 | 947 | 0.330 |
Why?
|
| Hydroxyeicosatetraenoic Acids | 1 | 2010 | 225 | 0.330 |
Why?
|
| Radiographic Image Enhancement | 5 | 2010 | 877 | 0.300 |
Why?
|
| Monte Carlo Method | 3 | 2011 | 1262 | 0.300 |
Why?
|
| Liver Neoplasms | 6 | 2011 | 4363 | 0.290 |
Why?
|
| Respiratory Mechanics | 3 | 2010 | 722 | 0.280 |
Why?
|
| Radiotherapy Dosage | 12 | 2013 | 2920 | 0.280 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2008 | 515 | 0.260 |
Why?
|
| Thromboxane B2 | 1 | 2006 | 143 | 0.260 |
Why?
|
| Viscera | 1 | 2006 | 138 | 0.260 |
Why?
|
| Photogrammetry | 1 | 2006 | 77 | 0.260 |
Why?
|
| Radiometry | 4 | 2009 | 817 | 0.260 |
Why?
|
| Documentation | 1 | 2012 | 917 | 0.250 |
Why?
|
| Abdomen | 1 | 2011 | 1137 | 0.250 |
Why?
|
| Lipid Peroxidation | 1 | 2006 | 276 | 0.240 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 6 | 2010 | 5434 | 0.240 |
Why?
|
| Motion | 5 | 2010 | 794 | 0.220 |
Why?
|
| Abdominal Neoplasms | 1 | 2005 | 287 | 0.220 |
Why?
|
| Pattern Recognition, Automated | 2 | 2006 | 998 | 0.200 |
Why?
|
| Tomography, Spiral Computed | 1 | 2004 | 274 | 0.200 |
Why?
|
| Guideline Adherence | 1 | 2012 | 2240 | 0.190 |
Why?
|
| Sensitivity and Specificity | 10 | 2013 | 14751 | 0.190 |
Why?
|
| Software | 4 | 2008 | 4480 | 0.170 |
Why?
|
| Respiratory-Gated Imaging Techniques | 2 | 2010 | 75 | 0.170 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2006 | 1408 | 0.160 |
Why?
|
| Algorithms | 13 | 2010 | 14199 | 0.160 |
Why?
|
| Reproducibility of Results | 12 | 2013 | 20244 | 0.160 |
Why?
|
| Nitrosamines | 2 | 2010 | 86 | 0.160 |
Why?
|
| Radiology | 1 | 2012 | 2104 | 0.150 |
Why?
|
| Breast Neoplasms | 4 | 2010 | 21187 | 0.140 |
Why?
|
| Image Processing, Computer-Assisted | 5 | 2008 | 9081 | 0.140 |
Why?
|
| Nuclear Physics | 1 | 2017 | 73 | 0.140 |
Why?
|
| Particle Accelerators | 3 | 2008 | 173 | 0.140 |
Why?
|
| Surgical Instruments | 2 | 2010 | 385 | 0.130 |
Why?
|
| Image Interpretation, Computer-Assisted | 2 | 2006 | 3411 | 0.130 |
Why?
|
| Pancreatic Neoplasms | 2 | 2011 | 5443 | 0.130 |
Why?
|
| X-Rays | 3 | 2005 | 311 | 0.120 |
Why?
|
| Practice Guidelines as Topic | 1 | 2012 | 7460 | 0.120 |
Why?
|
| Electronic Health Records | 1 | 2012 | 4879 | 0.120 |
Why?
|
| Diagnostic Imaging | 1 | 2008 | 3538 | 0.120 |
Why?
|
| Artificial Intelligence | 2 | 2006 | 2665 | 0.110 |
Why?
|
| Computer Simulation | 2 | 2005 | 6289 | 0.110 |
Why?
|
| Radiotherapy, Intensity-Modulated | 2 | 2010 | 812 | 0.100 |
Why?
|
| Water | 2 | 2009 | 1421 | 0.100 |
Why?
|
| Michigan | 1 | 2012 | 336 | 0.100 |
Why?
|
| Mesenteric Artery, Superior | 1 | 2011 | 96 | 0.090 |
Why?
|
| Humans | 44 | 2013 | 768887 | 0.090 |
Why?
|
| Carcinoma, Large Cell | 2 | 2010 | 114 | 0.090 |
Why?
|
| Smoking | 1 | 2008 | 9094 | 0.090 |
Why?
|
| Fiducial Markers | 1 | 2011 | 134 | 0.090 |
Why?
|
| Lung | 5 | 2010 | 10097 | 0.090 |
Why?
|
| Mice, Inbred A | 1 | 2010 | 245 | 0.090 |
Why?
|
| Breast | 2 | 2009 | 1976 | 0.080 |
Why?
|
| Radiography | 3 | 2009 | 6991 | 0.080 |
Why?
|
| Scintillation Counting | 1 | 2009 | 36 | 0.080 |
Why?
|
| Models, Biological | 1 | 2005 | 9499 | 0.080 |
Why?
|
| Radiography, Abdominal | 1 | 2011 | 541 | 0.080 |
Why?
|
| S-Nitroso-N-Acetylpenicillamine | 1 | 2008 | 23 | 0.080 |
Why?
|
| Technology, Radiologic | 1 | 2008 | 160 | 0.080 |
Why?
|
| Mammography | 2 | 2009 | 2434 | 0.070 |
Why?
|
| Stomach | 1 | 2011 | 702 | 0.070 |
Why?
|
| PPAR gamma | 1 | 2010 | 487 | 0.070 |
Why?
|
| Staurosporine | 1 | 2008 | 241 | 0.070 |
Why?
|
| Uncertainty | 2 | 2010 | 769 | 0.070 |
Why?
|
| Radiography, Thoracic | 1 | 2013 | 1321 | 0.070 |
Why?
|
| Exhalation | 1 | 2007 | 185 | 0.070 |
Why?
|
| Organ Size | 1 | 2011 | 2268 | 0.070 |
Why?
|
| Thiobarbituric Acid Reactive Substances | 1 | 2006 | 45 | 0.070 |
Why?
|
| Body Burden | 1 | 2006 | 158 | 0.060 |
Why?
|
| Equipment Design | 3 | 2009 | 3529 | 0.060 |
Why?
|
| Quality Control | 1 | 2008 | 836 | 0.060 |
Why?
|
| Thoracic Wall | 1 | 2008 | 204 | 0.060 |
Why?
|
| Cone-Beam Computed Tomography | 1 | 2010 | 459 | 0.060 |
Why?
|
| Caspase 3 | 1 | 2008 | 731 | 0.060 |
Why?
|
| Subtraction Technique | 2 | 2006 | 519 | 0.060 |
Why?
|
| Statistical Distributions | 1 | 2005 | 63 | 0.060 |
Why?
|
| Calibration | 1 | 2008 | 823 | 0.060 |
Why?
|
| Relative Biological Effectiveness | 1 | 2006 | 313 | 0.060 |
Why?
|
| Female | 15 | 2013 | 397464 | 0.060 |
Why?
|
| Aged, 80 and over | 5 | 2013 | 59738 | 0.060 |
Why?
|
| Iridium Radioisotopes | 1 | 2003 | 26 | 0.060 |
Why?
|
| Time Factors | 6 | 2010 | 40266 | 0.050 |
Why?
|
| Models, Statistical | 4 | 2009 | 5107 | 0.050 |
Why?
|
| Dose-Response Relationship, Radiation | 4 | 2005 | 877 | 0.050 |
Why?
|
| Intestines | 1 | 2011 | 1911 | 0.050 |
Why?
|
| Mastectomy, Segmental | 1 | 2008 | 960 | 0.050 |
Why?
|
| Hair Follicle | 1 | 2004 | 219 | 0.050 |
Why?
|
| Yttrium Radioisotopes | 1 | 2003 | 114 | 0.050 |
Why?
|
| Biophysical Phenomena | 1 | 2003 | 320 | 0.050 |
Why?
|
| Statistics, Nonparametric | 1 | 2008 | 2862 | 0.050 |
Why?
|
| Diaphragm | 1 | 2004 | 357 | 0.050 |
Why?
|
| Prostatic Neoplasms | 1 | 2005 | 11229 | 0.050 |
Why?
|
| Biophysics | 1 | 2003 | 379 | 0.050 |
Why?
|
| Cranial Irradiation | 1 | 2004 | 395 | 0.050 |
Why?
|
| Aged | 9 | 2013 | 171790 | 0.050 |
Why?
|
| Principal Component Analysis | 1 | 2005 | 948 | 0.050 |
Why?
|
| Models, Anatomic | 1 | 2005 | 683 | 0.050 |
Why?
|
| Tumor Burden | 1 | 2007 | 1913 | 0.050 |
Why?
|
| Dura Mater | 1 | 2003 | 297 | 0.050 |
Why?
|
| Neoplasms | 3 | 2004 | 22390 | 0.050 |
Why?
|
| Male | 13 | 2013 | 365249 | 0.050 |
Why?
|
| Posture | 1 | 2004 | 957 | 0.040 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2010 | 2848 | 0.040 |
Why?
|
| Alopecia | 1 | 2004 | 416 | 0.040 |
Why?
|
| Information Storage and Retrieval | 1 | 2005 | 831 | 0.040 |
Why?
|
| Middle Aged | 8 | 2013 | 223740 | 0.040 |
Why?
|
| Photons | 1 | 2003 | 595 | 0.040 |
Why?
|
| Dogs | 1 | 2004 | 3845 | 0.040 |
Why?
|
| Nitric Oxide | 1 | 2008 | 2149 | 0.040 |
Why?
|
| Liver | 2 | 2011 | 7579 | 0.040 |
Why?
|
| Neoplasm Proteins | 1 | 2010 | 3608 | 0.040 |
Why?
|
| Spinal Neoplasms | 1 | 2003 | 715 | 0.030 |
Why?
|
| Radiation Oncology | 1 | 2003 | 572 | 0.030 |
Why?
|
| Kidney | 1 | 2011 | 7057 | 0.030 |
Why?
|
| Switzerland | 1 | 2017 | 323 | 0.030 |
Why?
|
| Brachytherapy | 1 | 2003 | 1224 | 0.030 |
Why?
|
| Neoplasm Staging | 2 | 2010 | 11262 | 0.030 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2010 | 5342 | 0.030 |
Why?
|
| Feasibility Studies | 4 | 2009 | 5323 | 0.030 |
Why?
|
| Image Enhancement | 1 | 2005 | 2898 | 0.030 |
Why?
|
| Heart | 1 | 2007 | 4448 | 0.030 |
Why?
|
| Disease Progression | 1 | 2010 | 13677 | 0.030 |
Why?
|
| Treatment Outcome | 4 | 2013 | 65485 | 0.020 |
Why?
|
| History, 21st Century | 1 | 2017 | 1575 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2010 | 18366 | 0.020 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2010 | 11886 | 0.020 |
Why?
|
| Retrospective Studies | 4 | 2011 | 81892 | 0.020 |
Why?
|
| History, 20th Century | 1 | 2017 | 2771 | 0.020 |
Why?
|
| Solutions | 1 | 2009 | 410 | 0.020 |
Why?
|
| Silicones | 1 | 2009 | 228 | 0.020 |
Why?
|
| Computer Systems | 1 | 2009 | 470 | 0.020 |
Why?
|
| Computer-Aided Design | 1 | 2009 | 296 | 0.020 |
Why?
|
| Nipples | 1 | 2009 | 229 | 0.020 |
Why?
|
| Equipment Failure Analysis | 1 | 2009 | 848 | 0.020 |
Why?
|
| Surface Properties | 1 | 2009 | 1169 | 0.020 |
Why?
|
| Mutation | 1 | 2010 | 30266 | 0.020 |
Why?
|
| Systole | 1 | 2007 | 937 | 0.020 |
Why?
|
| Animals | 2 | 2010 | 169408 | 0.020 |
Why?
|
| DNA, Neoplasm | 1 | 2010 | 1748 | 0.020 |
Why?
|
| Diastole | 1 | 2007 | 784 | 0.020 |
Why?
|
| Exons | 1 | 2010 | 2395 | 0.010 |
Why?
|
| Mice | 1 | 2010 | 82074 | 0.010 |
Why?
|
| Spinal Cord Neoplasms | 1 | 2003 | 263 | 0.010 |
Why?
|
| Lasers | 1 | 2005 | 952 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2010 | 6085 | 0.010 |
Why?
|
| Intraoperative Care | 1 | 2003 | 771 | 0.010 |
Why?
|
| Radiation Injuries | 1 | 2006 | 1203 | 0.010 |
Why?
|
| Statistics as Topic | 1 | 2005 | 2359 | 0.010 |
Why?
|
| Thoracic Vertebrae | 1 | 2003 | 614 | 0.010 |
Why?
|
| Cholangiocarcinoma | 1 | 2004 | 562 | 0.010 |
Why?
|
| Survival Rate | 1 | 2010 | 12873 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2004 | 6242 | 0.010 |
Why?
|
| Adult | 2 | 2008 | 223818 | 0.010 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2010 | 4064 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2010 | 8055 | 0.010 |
Why?
|
| Lumbar Vertebrae | 1 | 2003 | 1889 | 0.010 |
Why?
|
| Adenocarcinoma | 1 | 2010 | 6401 | 0.010 |
Why?
|
| Drug Delivery Systems | 1 | 2003 | 2238 | 0.010 |
Why?
|
| Models, Theoretical | 1 | 2004 | 3580 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2003 | 8559 | 0.010 |
Why?
|
| Positron-Emission Tomography | 1 | 2005 | 6673 | 0.000 |
Why?
|
| Follow-Up Studies | 1 | 2003 | 39394 | 0.000 |
Why?
|
Concepts
(183)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(14)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_